NYSE:TDOCHealthcare Services
A Look At Teladoc Health’s Valuation As 2025 Results And 2026 Outlook Refocus Attention On The Stock
Teladoc Health (TDOC) is back in focus after reporting fourth quarter and full year 2025 results, updating its 2026 outlook, and adding experienced finance executive Michael S. Smith to its board.
See our latest analysis for Teladoc Health.
Teladoc Health’s recent earnings update, 2026 guidance and board appointment come against a weak backdrop, with a 7 day share price return of 10.97% contrasting with a 30 day share price return of 8.36% and a 1 year total shareholder return decline of...